Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

NCT07298408 is registered in ClinicalTrials.gov with Florida A&M University as lead sponsor.

NCT NCT07298408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07298408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Lead sponsor
Florida A&M University
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 2, 2026
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathies, diabetic peripheral neuropathic pain (dpn)